Adjuvant cytokine-induced killer cell immunotherapy improves long-term survival in patients with stage I–II non-small cell lung cancer after curative surgery-Reference-Cited by-同舟云学术

Adjuvant cytokine-induced killer cell immunotherapy improves long-term survival in patients with stage I–II non-small cell lung cancer after curative surgery

Published:2023-02 Issue:2 Volume:25 Page:202-209
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Huang Jianmin,Zhao Xuan,Zhang Zhen,Yang Shuangning,Chen Xinfeng,Shen Chunyi,Wang Liping,Qi Yu,Zhang Yi

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference46 articles.

1. Therapeutic advances in non-small cell lung cancer: focus on clinical development of targeted therapy and immunotherapy;Cheng;MedComm,2021

2. Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients;Bille;European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery,2017

3. Current Surgical Indications for Non-Small-Cell Lung Cancer;Deboever;Cancers,2022

4. High Densities of Tumor-Associated Plasma Cells Predict Improved Prognosis in Triple Negative Breast Cancer;Yeong;Frontiers in immunology,2018

5. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer;Zhang;N Engl J Med,2003

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repolarizing Tumor-Associated Macrophages and inducing immunogenic cell Death: A targeted liposomal strategy to boost cancer immunotherapy;International Journal of Pharmaceutics;2024-02